ArticleFrontiers in pharmacology2020

Factors Influencing the Steady-State Plasma Concentration of Imatinib Mesylate in Patients With Gastrointestinal Stromal Tumors and Chronic Myeloid Leukemia.

Yan Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.